US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Dec 20, 2018 (8 years ago)

Losartan Potassium Tablets

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

What was recalled

LOSARTAN POTASSIUM TABLETS, USP, 50 mg, a) 30-count bottle (NDC: 13668-409-30), b) 90-count bottle (NDC: 13668-409-90), c) 1000-count bottle (NDC: 13668-409-10), Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana Inda

Recalling firm
Torrent Pharma Inc.
Origin
MI, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0502-2019

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Losartan recalls

See all
Class II · Moderate risk Terminated

Losartan Potassium Tablets

Reason Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.

Strides Pharma Inc. NDC 64380-933-08 D-0895-2023
Class II · Moderate risk Terminated

Losartan Potassium Tablets

Reason CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

PD-Rx Pharmaceuticals, Inc. NDC 72789-165-90 D-1163-2022
Class II · Moderate risk Terminated

Losartan Potassium Tablets

Reason CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

PD-Rx Pharmaceuticals, Inc. NDC 72789-164-90 D-1162-2022